European Journal of Internal Medicine
Volume 18, Issue 4 , Pages 267-271 , July 2007

STAT1 and STAT3 as intracellular regulators of vascular remodeling

  • Andrzej Wincewicz

      Affiliations

    • Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland
    • Corresponding Author InformationCorresponding author. Department of Pathology, Medical University of Bialystok, Waszyngtona St 13, 15-269 Bialystok, Poland. Tel.: +48 85 748 59 45; fax: +48 85 748 59 44.
    • ,
  • Mariola Sulkowska

      Affiliations

    • Department of Pediatric Allergology, Waszyngtona St 17, 15-274 Bialystok, Dr Ludwik Zamenhof Memorial Children Clinic Hospital, Medical University of Bialystok, Poland
    • ,
  • Ryszard Rutkowski

      Affiliations

    • Department of Pediatric Allergology, Waszyngtona St 17, 15-274 Bialystok, Dr Ludwik Zamenhof Memorial Children Clinic Hospital, Medical University of Bialystok, Poland
    • ,
  • Stanislaw Sulkowski

      Affiliations

    • Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland
    • ,
  • Boguslaw Musiatowicz

      Affiliations

    • Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland
    • ,
  • Tomasz Hirnle

      Affiliations

    • Department of Cardiac Surgery, M. Skłodowskiej-Curie St 24A, 15-276 Public Clinic Hospital of Medical University in Bialystok, Poland
    • ,
  • Waldemar Famulski

      Affiliations

    • Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland
    • ,
  • Mariusz Koda

      Affiliations

    • Department of Pathology, Waszyngtona St 13, 15-269 Białystok, Collegium Pathologicum, Medical University of Bialystok, Poland
    • ,
  • Grzegorz Sokol

      Affiliations

    • Traumathology Unit Frederick Chopin Memorial Voivodeship Specialistic Hospital of Rzeszow, Poland
    • ,
  • Przemyslaw Szarejko

      Affiliations

    • Department of Family Medicine and Community Nursing, Medical University of Bialystok, Mieszka I St 4B, 15-054 Bialystok, Poland

Received 12 August 2006 ,Accepted 29 December 2006.

References 

  1. Akira S. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells. 1999;17:138–146
  2. Wang Y, Malabarba MG, Nagy ZS, Kirken RA. Interleukin 4 regulates phosphorylation of serine 756 in the transactivation domain of Stat6. Roles for multiple phosphorylation sites and Stat6 function. J Biol Chem. 2004;279:25196–25203
  3. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol. 2003;197:157–168
  4. Varinou L, Ramsauer K, Karaghiosoff M, Kolbe T, Pfeffer K, Muller M, et al. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity. 2003;19:793–802
  5. Levy DE, Lee CK. What does Stat3 do?. J Clin Invest. 2002;109:1143–1148
  6. Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139–1142
  7. Maziere C, Conte MA, Maziere JC. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med. 2001;31:1334–1340
  8. Davignon J, Jacob RF, Mason RP. The antioxidant effects of statins. Coron Artery Dis. 2004;15:251–258
  9. Yellaturu CR, Rao GN. Cytosolic phospholipase A2 is an effector of Jak/STAT signaling and is involved in platelet-derived growth factor BB-induced growth in vascular smooth muscle cells. J Biol Chem. 2003;278:9986–9992
  10. Peilot H, Rosengren B, Bondjers G, Hurt-Camejo E. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J Biol Chem. 2000;275:22895–22904
  11. Cattaruzza M, Slodowski W, Stojakovic M, Krzesz R, Hecker M. Interleukin-10 induction of nitric oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells. J Biol Chem. 2003;278:37874–37880
  12. Lian RH, Kotwal GJ, Hunt LA, Wilson MA, Justus DE. Dextran sulfate inhibits IFN-gamma-induced Jak–Stat pathway in human vascular endothelial cells. Cell Immunol. 1992;192:140–148
  13. Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai GX, Hansen W, et al. Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med. 2003;198:1517–1525
  14. Douglas MS, Ali S, Rix DA, Zhang JG, Kirby JA. Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. Immunology. 1997;92:512–518
  15. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med. 1998;187:675–683
  16. Sadeghi MM, Tiglio A, Sadigh K, O'Donnell L, Collinge M, Pardi R, et al. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation. 2001;71:1262–1268
  17. Wagner AH, Schwabe O, Hecker M. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. Br J Pharmacol. 2002;136:143–149
  18. Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol. 2005;175:4662–4668
  19. Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S, et al. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1beta. Circ Res. 1999;85:1124–1131
  20. Mahboubi K, Pober JS. Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M. J Biol Chem. 2002;277:8012–8021
  21. Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, et al. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem. 2003;278:40026–40031
  22. Osugi T, Oshima Y, Fujio Y, Funamoto M, Yamashita A, Negoro S, et al. Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart. J Biol Chem. 2002;277:6676–6681
  23. Enaida H, Kabuyama Y, Oshima Y, Sakamoto T, Kato K, Kochi H, et al. VEGF-dependent signaling in retinal microvascular endothelial cells. Fukushima J Med Sci. 1999;45:77–91
  24. Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, Marrero MB, et al. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem. 2000;275:33189–33192
  25. Schmitz U, Ishida T, Ishida M, Surapisitchat J, Hasham MI, Pelech S, et al. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK. Circ Res. 1998;82:1272–1278
  26. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem. 1997;272:24684–24690
  27. Schieffer B, Bernstein KE, Marrero MB. The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth. J Mol Med. 1996;74:85–91
  28. Schieffer B, Paxton WG, Chai Q, Marrero MB, Bernstein KE. Angiotensin II controls p21ras activity via pp60c-src. J Biol Chem. 1996;271:10329–10333
  29. Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, et al. Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest. 2001;81:327–334
  30. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension. 2001;37:581–586
  31. Shibata R, Kai H, Seki Y, Kato S, Wada Y, Hanakawa Y, et al. Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells. Hum Gene Ther. 2003;14:601–610

PII: S0953-6205(07)00083-0

doi: 10.1016/j.ejim.2006.12.007

European Journal of Internal Medicine
Volume 18, Issue 4 , Pages 267-271 , July 2007

Article Tools